Linarol-M Tablet 2.5 mg+850 mg is a combination oral antidiabetic medication containing Linagliptin (2.5 mg) and Metformin Hydrochloride (850 mg). It is formulated for adults with type 2 diabetes mellitus whose blood glucose levels are inadequately controlled by diet, exercise, or monotherapy with either Linagliptin or Metformin.

This dual-action formulation provides comprehensive blood sugar management. Linagliptin, a DPP-4 inhibitor, enhances glucose-dependent insulin secretion and suppresses glucagon release, while Metformin improves insulin sensitivity in peripheral tissues and decreases hepatic glucose production. Together, they help control both fasting and postprandial blood glucose levels, improving overall glycemic stability and reducing the risk of diabetes-related complications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

The combination of Linagliptin and Metformin in Linarol-M Tablet acts through complementary mechanisms:

• Linagliptin (2.5 mg): Inhibits the DPP-4 enzyme, prolonging the action of incretin hormones (GLP-1 and GIP). This increases insulin secretion when blood sugar is elevated and reduces glucagon secretion, lowering hepatic glucose output.

• Metformin (850 mg): Improves insulin sensitivity in muscle and fat tissues, reduces glucose production by the liver, and enhances peripheral glucose utilization.

• Synergistic effect: Together, these actions provide sustained glycemic control, minimize post-meal glucose spikes, and help maintain stable blood sugar levels throughout the day.

This combination is ideal for patients requiring more potent glycemic control than lower-dose formulations.

Indications

Linarol-M Tablet 2.5 mg+850 mg is indicated for:

• Type 2 diabetes mellitus: For patients whose blood sugar is not adequately controlled with diet, exercise, or monotherapy.

• Combination therapy for optimal glycemic control: Can be used with other oral antidiabetic agents or insulin under medical supervision.

• Postprandial glucose management: Helps reduce high blood sugar spikes after meals and improves overall glycemic stability.

It is not suitable for type 1 diabetes, diabetic ketoacidosis, or patients with severe renal or hepatic impairment.

Dosage and Administration

• The usual dose is 1 tablet once or twice daily, taken with meals to reduce gastrointestinal side effects from Metformin.

• Swallow the tablet whole with water; do not crush or chew.

• Dose adjustment may be required based on blood glucose monitoring, HbA1c, and clinical response, under medical supervision.

• Regular monitoring of fasting and postprandial glucose, as well as HbA1c, is recommended to assess treatment effectiveness.

• Continue following a balanced diet, exercise regimen, and lifestyle modifications for optimal blood sugar control.

Precautions

• Caution is advised in patients with renal or hepatic impairment, as Metformin may rarely cause lactic acidosis.

• Hypoglycemia may occur, especially if used with other antidiabetic medications, irregular meals, or excessive physical activity.

• Inform your doctor about any cardiovascular disease, pancreatitis, or history of severe lactic acidosis.

• Limit alcohol consumption, as it may increase the risk of hypoglycemia or lactic acidosis.

• Consult a physician before use during pregnancy or breastfeeding.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Hypoglycemia (dizziness, sweating, fatigue, confusion)

• Gastrointestinal disturbances: nausea, vomiting, diarrhea, or mild abdominal discomfort

• Headache

• Joint pain

Rare but serious side effects may include:

• Pancreatitis (severe abdominal pain, nausea, vomiting)

• Severe allergic reactions (rash, swelling, difficulty breathing)

• Lactic acidosis (very rare)

Seek immediate medical attention if severe or persistent symptoms occur.

Storage

Store below 30°C in a dry, cool place away from direct sunlight and moisture. Keep out of reach of children.

Linarol-M Tablet 2.5 mg+850 mg provides effective dual-action therapy for type 2 diabetes, combining Linagliptin and Metformin to maintain stable blood glucose levels, enhance insulin function, and reduce long-term complications under medical supervision.